Identification and validation of a platelet-related signature for predicting survival and drug sensitivity in multiple myeloma

• Egile Nagusiak: Zhili Lin (Egilea), Quanqiang Wang (Egilea), Ziwei Zheng (Egilea), Bingxin Zhang (Egilea), Shujuan Zhou (Egilea), Dong Zheng (Egilea), Zixing Chen (Egilea), Sisi Zheng (Egilea), Shuxia Zhu (Egilea), Xinyi Zhang (Egilea), Enqing Lan (Egilea), Yu Zhang (Egilea), Xuanru Lin (Egilea), Qiang Zhuang (Egilea), Honglan Qian (Egilea), Xudong Hu (Egilea), Yan Zhuang (Egilea), Zhouxiang Jin (Egilea), Songfu Jiang (Egilea), Yongyong Ma (Egilea)
• Formatua: Liburua
• Argitaratua: Frontiers Media S.A., 2024-05-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Background: Significant progress has been achieved in the management of multiple myeloma (MM) by implementing high-dose therapy and stem cell transplantation. Moreover, the prognosis of patients has been enhanced due to the introduction of novel immunomodulatory drugs and the emergence of new target...